Navamedic has completed the sale of Glucomed for NOK 40.5 million

Report this content
(Lysaker, 3 September 2009): Navamedic has today, 3 September completed the sale of Glucomed to Laboratoires Expanscience. The company has received EUR 4.65 million, app. NOK 40.5 million.



For further information, please contact:
Bernt-Olav Røttingsnes, CFO/IRO Navamedic ASA
E-mail: bor@navamedic.com
Mobile: +47 91 34 70 21


Subscribe